Products billed under this code include Duramorph, Infumorph 200, Infumorph 500, Mitigo, Morphine Sulfate.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Duramorph | Hikma Pharmaceuticals USA Inc. | 00641-6019-10 | 10 | $160.44 |
| Duramorph | Hikma Pharmaceuticals USA Inc. | 00641-6020-10 | 5 | $80.22 |
| Infumorph 200 | Hikma Pharmaceuticals USA Inc. | 00641-6039-01 | 20 | $320.88 |
| Infumorph 500 | Hikma Pharmaceuticals USA Inc. | 00641-6040-01 | 50 | $802.20 |
| Mitigo | Piramal Critical Care Inc | 66794-0160-02 | 20 | $320.88 |
| Mitigo | Piramal Critical Care Inc | 66794-0162-02 | 50 | $802.20 |
| Morphine Sulfate | Pfizer Inc | 00409-3814-12 | 3 | $48.132 |
| Morphine Sulfate | Pfizer Inc | 00409-3815-12 | 5 | $80.22 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $16.044 | −$2.87 | 10 MG | Inj morphine pf epid ithc | v1, posted September 17, 2026 |
| 3Q26 | $18.914 | +$6.765 | 10 MG | Inj morphine pf epid ithc | v1, posted September 15, 2026 |
| 2Q26 | $12.149 | −$1.346 | 10 MG | Inj morphine pf epid ithc | v1, posted September 15, 2026 |
| 1Q26 | $13.495 | +$1.44 | 10 MG | Inj morphine pf epid ithc | v1, posted September 15, 2026 |
| 4Q25 | $12.055 | +$1.263 | 10 MG | Inj morphine pf epid ithc | v1, posted September 8, 2026 |
| 3Q25 | $10.792 | +$0.971 | 10 MG | Inj morphine pf epid ithc | v1, posted March 10, 2026 |
| 2Q25 | $9.821 | −$1.729 | 10 MG | Inj morphine pf epid ithc | v1, posted March 10, 2026 |
| 1Q25 | $11.55 | +$1.087 | 10 MG | Inj morphine pf epid ithc | v1, posted December 19, 2025 |
| 4Q24 | $10.463 | −$0.019 | 10 MG | Inj morphine pf epid ithc | v1, posted June 11, 2025 |
| 3Q24 | $10.482 | −$3.952 | 10 MG | Inj morphine pf epid ithc | v1, posted June 11, 2025 |
| 2Q24 | $14.434 | +$3.19 | 10 MG | Inj morphine pf epid ithc | v1, posted March 11, 2025 |
| 1Q24 | $11.244 | +$0.054 | 10 MG | Inj morphine pf epid ithc | v1, posted December 19, 2024 |
| 4Q23 | $11.19 | −$4.511 | 10 MG | Inj morphine pf epid ithc | v1, posted October 10, 2024 |
| 3Q23 | $15.701 | −$1.004 | 10 MG | Inj morphine pf epid ithc | v1, posted June 5, 2024 |
| 2Q23 | $16.705 | +$7.604 | 10 MG | Inj morphine pf epid ithc | v1, posted February 23, 2024 |
| 1Q23 | $9.101 | −$2.73 | 10 MG | Inj morphine pf epid ithc | v1, posted December 6, 2023 |
| 4Q22 | $11.831 | +$0.302 | 10 MG | Inj morphine pf epid ithc | v1, posted June 22, 2023 |
| 3Q22 | $11.529 | −$10.806 | 10 MG | Inj morphine pf epid ithc | v1, posted June 9, 2023 |
| 2Q22 | $22.335 | +$8.446 | 10 MG | Inj morphine pf epid ithc | v1, posted December 14, 2022 |
| 1Q22 | $13.889 | +$2.813 | 10 MG | Inj morphine pf epid ithc | v1, posted June 8, 2022 |
| 4Q21 | $11.076 | +$2.361 | 10 MG | Inj morphine pf epid ithc | v1, posted June 2, 2022 |
| 3Q21 | $8.715 | −$2.156 | 10 MG | Inj morphine pf epid ithc | v1, posted June 2, 2022 |
| 2Q21 | $10.871 | −$0.642 | 10 MG | Inj morphine pf epid ithc | v1, posted March 1, 2022 |
| 1Q21 | $11.513 | – | 10 MG | Inj morphine pf epid ithc | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
